Market access landscape and strategy

As your product moves through clinical development, we work with you from as early as the pre-clinical stage to inform key business decisions relating to pricing, access, and evidence.


Your business challenges are our priority, and we will partner with you to enable informed market access trade-offs and strategy.


We can help you identify challenges and opportunities for your product with landscape assessments of current and potential future treatment, pricing, reimbursement, and evidence generation requirements in your target therapy area across health technology assessment (HTA) and non-HTA markets.


You will gain high-value insights on how key stakeholders are likely to perceive your asset, the best approaches to maximize value, likely challenges, risk mitigation, and likely P&R outcomes.


Our consulting solutions include:

  • Payer landscape assessments
  • Payer/market segmentation
  • Market access opportunity assessments
  • Market access strategy and roadmaps


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

You helped us to capture a comprehensive analysis of the overall landscape beyond the scope of what we would typically undertake internally, in a convenient platform for dissemination.

Director, Global HEOR, top-20 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.